Back
Cellectar Biosciences Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
7
CLRB
Cellectar Biosciences
Last Price:
$5.02
Seasonality Move:
-13.76%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLRB is experiencing slight selling pressure.
Cellectar Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.87 | Buy |
| 20-day SMA: | 6.63 | Sell |
| 50-day SMA: | 8.01 | Sell |
| 200-day SMA: | 21.4 | Sell |
| 8-day EMA: | 4.06 | Buy |
| 20-day EMA: | 2.46 | Buy |
| 50-day EMA: | 1.19 | Buy |
| 200-day EMA: | 0.33 | Buy |
Cellectar Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.34 | Buy |
| Relative Strength Index (14 RSI): | 36.58 | Sell |
| Chaikin Money Flow: | -37540 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.78 - 10.68) | Sell |
| Bollinger Bands (100): | (6.63 - 10.57) | Sell |
Cellectar Biosciences Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cellectar Biosciences Stock
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 5.04 while CLRB 8-day simple moving average is 4.87, which is a Buy signal.
-
The stock price of CLRB is 5.04 while Cellectar Biosciences 20-day SMA is 6.63, which makes it a Sell.
-
Cellectar Biosciences 50-day simple moving average is 8.01 while CLRB share price is 5.04, making it a Sell technically.
-
CLRB stock price is 5.04 and Cellectar Biosciences 200-day simple moving average is 21.40, creating a Sell signal.
CLRB Technical Analysis vs Fundamental Analysis
Sell
7
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy or a Sell?
-
Cellectar Biosciences stock is rated a SellThe current Cellectar Biosciences [CLRB] share price is $5.04. The Score for CLRB is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
Cellectar Biosciences Stock Info
Market Cap:
9.1M
Price in USD:
5.04
Share Volume:
157.7K
Cellectar Biosciences 52-Week Range
52-Week High:
94.50
52-Week Low:
4.36
Sell
7
Cellectar Biosciences (CLRB)
is a Sell
Cellectar Biosciences Share Price Forecast
-
What is the Cellectar Biosciences stock price today?The Cellectar Biosciences stock price is 5.04 USD today.
-
Will CLRB stock go up or go down?Cellectar Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Cellectar Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cellectar Biosciences is overvalued.
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 5.04 while CLRB 8-day exponential moving average is 4.06, which is a Buy signal.
-
The stock price of CLRB is 5.04 while Cellectar Biosciences 20-day EMA is 2.46, which makes it a Buy.
-
Cellectar Biosciences 50-day exponential moving average is 1.19 while CLRB share price is 5.04, making it a Buy technically.
-
CLRB stock price is 5.04 and Cellectar Biosciences 200-day simple moving average is 0.33, creating a Buy signal.
Fundamental Analysis of Cellectar Biosciences
Is Cellectar Biosciences a good investment?
-
Analysts estimate an earnings increase this quarter of $7.60 per share, a decrease next quarter of $2.40 per share, an increase this year of $31.63 per share, and a decrease next year of $0.88 per share.
Technical Analysis of Cellectar Biosciences
Should I short Cellectar Biosciences stock?
-
CLRB Moving Average Covergence Divergence (MACD) indicator is 1.34, suggesting Cellectar Biosciences is a Buy
-
Cellectar Biosciences Relative Strength Index (RSI) is 36.58, which suggest Cellectar Biosciences is oversold
-
The Bollinger Bands (25) for Cellectar Biosciences is (4.78 - 10.68), which suggest Cellectar Biosciences is a Sell
-
The Bollinger Bands (100) for Cellectar Biosciences is (6.63 - 10.57), which suggest Cellectar Biosciences is a Sell
* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.